June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
NOVEL TECHNIQUE: A PUPILLOMETER-BASED OBJECTIVE CHROMATIC PERIMETRY
Author Affiliations & Notes
  • Ygal Rotenstreich
    Goldschleger Eye Research Institute, Sheba Medical Center, Tel Hashomer, Israel
  • Alon Skaat
    Goldschleger Eye Research Institute, Sheba Medical Center, Tel Hashomer, Israel
  • Ifat Sher-Rosenthal
    Goldschleger Eye Research Institute, Sheba Medical Center, Tel Hashomer, Israel
  • Andrew Kolker
    Department of Ophthalmology, George Washington University, Washington, DC
  • Elkana Rosenfeld
    Goldschleger Eye Research Institute, Sheba Medical Center, Tel Hashomer, Israel
  • Shlomo Melamed
    Goldschleger Eye Research Institute, Sheba Medical Center, Tel Hashomer, Israel
  • Michael Belkin
    Goldschleger Eye Research Institute, Sheba Medical Center, Tel Hashomer, Israel
  • Footnotes
    Commercial Relationships Ygal Rotenstreich, PCT/L2010/00624 (P), Sheba Medical Center (P); Alon Skaat, None; Ifat Sher-Rosenthal, None; Andrew Kolker, None; Elkana Rosenfeld, None; Shlomo Melamed, Solx (F), Eyetechcare (F), Ioptima (F), Allergan (F); Michael Belkin, Alcon (C), Ellex (C), PCT: IL2011/000373 Filed 9/5/2011 Published (P)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 3944. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ygal Rotenstreich, Alon Skaat, Ifat Sher-Rosenthal, Andrew Kolker, Elkana Rosenfeld, Shlomo Melamed, Michael Belkin; NOVEL TECHNIQUE: A PUPILLOMETER-BASED OBJECTIVE CHROMATIC PERIMETRY. Invest. Ophthalmol. Vis. Sci. 2013;54(15):3944.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Quantification of the pupil response to chromatic light stimuli can be used to assess rod, cone, and melanopsin-containing ganglion cell activity. Here we developed a novel objective perimetry technique based on the pupil response to multifocal chromatic stimuli in normal subjects and in patients with glaucoma and retinitis pigmentosa (RP).

Methods: A computerized infrared video pupillometer was used to record changes in pupil diameter in response to short- and long-wavelength stimuli (peak 485 nm and 620 nm, respectively) size V, at light intensities of 15-100 cd-s/m2 and duration of 1000 ms at different points of the visual field. The RP patient group included 16 eyes of 8 patients and the normal group included 18 eyes of 11 subjects. The glaucoma patient group included 22 eyes of 11 patients and the normal group included 38 eyes of 19 subjects.

Results: Significantly reduced pupillary responses were obtained in RP patients under testing conditions that emphasized rod contribution (short-wavelength stimuli at 40 cd-s/m2) in nearly all perimetric locations (P <0.05). The glaucoma group showed significantly reduced pupillary responses under testing conditions that emphasized ganglion cell contribution (short-wavelength stimuli at high intensity) in all perimetric locations (P <0.05) as well as reduced pupillary responses under conditions that emphasized rod contribution mostly in nasal areas (p<0.05). By contrast, both patient groups demonstrated nearly normal pupillary responses under testing conditions that emphasized cone cell contribution (long-wavelength stimuli at high intensity) in majority of perimetric locations.

Conclusions: This study demonstrates the feasibility of using pupillometer-based chromatic perimetry for objectively assessing visual field defects and retinal function in patients with retinal dystrophies and glaucoma. Furthermore, this method may be used to distinguish between the damaged cells underlying the visual field defect.

Keywords: 758 visual fields • 642 perimetry • 612 neuro-ophthalmology: diagnosis  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×